CNS pipeline · person
Jason Pitts, PhD
Board member of Seaport Therapeutics and Vice President at General Atlantic, focused on life sciences. Previously Principal at Sofinnova Investments and an Associate at McKinsey, with prior board roles at CinCor (acquired by AstraZeneca) and Bolt Biotherapeutics.
- 1 company
Courtesy Seaport Therapeutics
Current roles
- Seaport Therapeutics, Inc.Board Member · Board
Appears with
People sharing a company with Jason.
- Antony Loebel · Seaport Therapeutics, Inc.
- Bob Hombach · Seaport Therapeutics, Inc.
- Daphne Zohar · Seaport Therapeutics, Inc.
- David Wheadon · Seaport Therapeutics, Inc.
- Denice Torres · Seaport Therapeutics, Inc.
- Eric Green · Seaport Therapeutics, Inc.
- Jim Healy · Seaport Therapeutics, Inc.
- Lana Gladstein · Seaport Therapeutics, Inc.
- Lauren White · Seaport Therapeutics, Inc.
- Michael Chen · Seaport Therapeutics, Inc.
- Sandi Peterson · Seaport Therapeutics, Inc.
- Sharon Mates · Seaport Therapeutics, Inc.
- Steven Paul · Seaport Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.